pI: 7.8625 |
Length (AA): 661 |
MW (Da): 78063 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
9 | 185 | 1byr (A) | 2 | 152 | 15.00 | 0 | 0.56 | 0.22 | -0.68 |
1 | 642 | 1v0w (A) | 50 | 508 | 13.00 | 0 | 0.99 | 0.455456 | 1.31 |
13 | 177 | 3hsi (A) | 27 | 189 | 28.00 | 0.000003 | 0.98 | 0.556622 | -0.47 |
267 | 416 | 4u5a (C) | 62 | 238 | 22.00 | 0.64 | 0.05 | 0.414729 | -0.56 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite. | PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, merozoite, Ring, Male Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Female Gametocyte. | Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Oocyst, Sporozoite. | Zanghi G |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_128543)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_IV011790 | phosphatidylglycerophosphate synthase, putative |
Brugia malayi | Bm1_19760 | Phospholipase D. Active site motif family protein |
Candida albicans | CaO19.7072 | phosphatidylglycerolphosphate synthase |
Candida albicans | CaO19_7072 | hypothetical protein |
Caenorhabditis elegans | CELE_Y48G1C.4 | Protein PGS-1 |
Cryptosporidium hominis | Chro.20123 | silencer-associated factor |
Cryptosporidium parvum | cgd2_1110 | silencer-associated factor, putative |
Dictyostelium discoideum | DDB_G0277037 | phosphatidylglycerophosphate synthase 1 |
Drosophila melanogaster | Dmel_CG7718 | CG7718 gene product from transcript CG7718-RA |
Escherichia coli | b2585 | phosphatidylserine synthase (CDP-diacylglycerol-serine O-phosphatidyltransferase) |
Echinococcus granulosus | EgrG_000624900 | CDP diacylglycerol glycerol 3 phosphate |
Echinococcus multilocularis | EmuJ_000625250 | leukocyte receptor cluster |
Echinococcus multilocularis | EmuJ_000624900 | CDP diacylglycerol glycerol 3 phosphate |
Homo sapiens | ENSG00000087157 | phosphatidylglycerophosphate synthase 1 |
Leishmania braziliensis | LbrM.07.0200 | phosphatidylglycerophosphate synthase, putative |
Leishmania donovani | LdBPK_070360.1 | phosphatidylglycerolphosphate synthase, mitochondrial, putative |
Leishmania infantum | LinJ.07.0360 | phosphatidylglycerophosphate synthase, putative |
Leishmania major | LmjF.07.0200 | phosphatidylglycerophosphate synthase, putative |
Leishmania mexicana | LmxM.07.0200 | phosphatidylglycerophosphate synthase-like protein |
Loa Loa (eye worm) | LOAG_11197 | hypothetical protein |
Loa Loa (eye worm) | LOAG_06803 | hypothetical protein |
Mus musculus | ENSMUSG00000017715 | phosphatidylglycerophosphate synthase 1 |
Plasmodium berghei | PBANKA_0710600 | phosphatidylglycerophosphate synthase, putative |
Plasmodium falciparum | PF3D7_0820200 | phosphatidylglycerophosphate synthase |
Plasmodium knowlesi | PKNH_1314000 | phosphatidylglycerophosphate synthase, putative |
Plasmodium vivax | PVX_089355 | phosphatidylglycerophosphate synthase, putative |
Plasmodium yoelii | PY03489 | phosphatidylglycerophosphate synthase-related |
Saccharomyces cerevisiae | YCL004W | CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase |
Schistosoma japonicum | Sjp_0027940 | ko:K00995 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase [EC2.7.8.5], putative |
Schistosoma japonicum | Sjp_0027930 | ko:K00998 phosphatidylserine synthase [EC2.7.8.8], putative |
Schistosoma mansoni | Smp_090820 | CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase |
Schmidtea mediterranea | mk4.002276.01 | CDP-diacylglycerolALQ-glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.8.1340 | phosphatidylglycerophosphate synthase-like protein, putative |
Trypanosoma brucei | Tb927.8.1720 | phosphatidylglycerolphosphate synthase, mitochondrial |
Trypanosoma congolense | TcIL3000_8_1620 | phosphatidylglycerolphosphate synthase, mitochondrial, putative |
Trypanosoma cruzi | TcCLB.505071.100 | phosphatidylglycerolphosphate synthase, mitochondrial, putative |
Trypanosoma cruzi | TcCLB.511395.20 | phosphatidylglycerolphosphate synthase, mitochondrial, putative |
Theileria parva | TP01_1130 | phosphatidylglycerophosphate synthase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.1720 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.1720 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.1720 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.1720 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2585 | Escherichia coli | essential | goodall |
CELE_Y48G1C.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
YCL004W | Saccharomyces cerevisiae | inviable | yeastgenome |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.